Skip to content

Clinical Outcomes of Home monitoring Uroflowmetry

Clinical Outcomes of Home monitoring Uroflowmetry

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220831001
Enrollment
30
Registered
2022-08-31
Start date
2020-12-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male with benign prostatic hyperplasia Benign prostatic hyperplasia. BPH. Home uroflowmetry. Home Uroflowmetry

Interventions

Male was diagnosed with BPH and used the new device, home-monitoring Uroflowmetry, at home.
Experimental Device

Sponsors

Faculty of Engineer. Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Men with diagnosed benign prostatic hyperplasia (BPH) Men can stand to void in the uroflowmetry. Men who lived in Bangkok and suburban areas.

Exclusion criteria

Exclusion criteria: Men diagnosed with benign prostate hyperplasia who do not have the indication for investigation with uroflowmetry

Design outcomes

Primary

MeasureTime frame
Satisfaction the end of use home uroflowmetry Rating scale

Secondary

MeasureTime frame
the maximum force of voiding end of every use Qmax (ml/second),frequency of voiding end of the day times,total voiding time end of voiding seconds

Countries

Thailand

Contacts

Public ContactChavalit Honglertsakul

Faculty of Medicine, Vajira hospital

chavalit@nmu.ac.th022443000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026